Ovarian Suppression Treatment Is Rare for Premenopausal Women with HR+/HER2+ Breast Cancer
In serious-environment follow, use of ovarian suppression treatment was not common amongst premenopausal individuals with
HRHER2
In serious-environment follow, use of ovarian suppression treatment was not common amongst premenopausal individuals with